Literature DB >> 3330789

A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.

J Milner1, A Cook, M Sheldon.   

Abstract

The PAb1620 antibody belongs to a group of monoclonal antibodies reported to recognize nuclear large T antigen of simian virus 40 (SV40). In the case of PAb1620 there was some indication that the antibody reacted preferentially with large T when it was complexed with p53, the cellular transformation-related antigen. However, we found that PAb1620 does not appear to react with SV40 large T, either free or in complex with p53. In this paper we demonstrate that PAb1620 is, in fact, directed against the p53 protein and recognizes a conformation-dependent epitope. In addition, PAb1620 recognises human p53 from SV80 cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3330789

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Repression of the basal c-fos promoter by wild-type p53.

Authors:  N Kley; R Y Chung; S Fay; J P Loeffler; B R Seizinger
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

2.  Mammalian p53 can function as a transcription factor in yeast.

Authors:  E Schärer; R Iggo
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

3.  Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.

Authors:  J Milner; E A Medcalf; A C Cook
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

4.  Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.

Authors:  L Wu; J H Bayle; B Elenbaas; N P Pavletich; A J Levine
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

5.  p53 DNA binding can be modulated by factors that alter the conformational equilibrium.

Authors:  K G McLure; P W Lee
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

6.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

7.  Isg15 controls p53 stability and functions.

Authors:  Yi-Fu Huang; Sheena Wee; Jayantha Gunaratne; David P Lane; Dmitry V Bulavin
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

8.  Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.

Authors:  Petr Muller; Juliana M Chan; Oliver Simoncik; Miroslav Fojta; David P Lane; Ted Hupp; Borivoj Vojtesek
Journal:  Protein Sci       Date:  2017-12-08       Impact factor: 6.725

9.  Inhibition of p53 DNA binding by human papillomavirus E6 proteins.

Authors:  M S Lechner; L A Laimins
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 10.  Awakening guardian angels: drugging the p53 pathway.

Authors:  Christopher J Brown; Sonia Lain; Chandra S Verma; Alan R Fersht; David P Lane
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.